These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11417384)

  • 1. Analysis of the expenses for drugs in the stationary departments of the united regional hospitals.
    Dimitrov D
    Boll Chim Farm; 2001; 140(2):108-11. PubMed ID: 11417384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the expenses for drugs in the stationary departments of the united regional hospitals.
    Dimitrov D
    Boll Chim Farm; 2003 Apr; 142(3):112-4. PubMed ID: 12806829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drugs in Spain -- when are they to be considered cost-effective alternatives and profitable investments for the National Health System? ].
    Soto Alvarez J
    Farm Hosp; 2004; 28(4):299-304. PubMed ID: 15369442
    [No Abstract]   [Full Text] [Related]  

  • 4. Two ophthalmology departments financed by compulsory health insurance: what is it that makes a difference in costs and clinical effectiveness?
    Nasić M; Oresković S
    Croat Med J; 2002 Aug; 43(4):433-8. PubMed ID: 12187521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social health insurance and drug spending among cancer inpatients in China.
    Zhou B; Yang L; Sun Q; Gu H; Wang B
    Health Aff (Millwood); 2008; 27(4):1020-7. PubMed ID: 18607036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug costs in departments of internal medicine. An analysis of costs for patients and departments].
    Rabøl R; Kolbye A; Andersen SE
    Ugeskr Laeger; 2003 Apr; 165(15):1565-8. PubMed ID: 12715661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Profit or loss--can handsurgery be profitable?].
    Hahn P; Off J
    Handchir Mikrochir Plast Chir; 2008 Jun; 40(3):211-3. PubMed ID: 18677794
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the Lublin Regional Health Board contract in 2002 in the selected departments of the state hospital health service of the Lublin region. Part I. Hospital beds as a criterion of contract evaluation].
    Grochowski L
    Wiad Lek; 2002; 55 Suppl 1(Pt 2):694-7. PubMed ID: 17474585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medicoeconomic results of the pediatric unit at Le Havre hospital].
    Le Luyer B; Daire I; Le Roux P; Briquet E
    Arch Pediatr; 2006 Jun; 13(6):588-91. PubMed ID: 16697566
    [No Abstract]   [Full Text] [Related]  

  • 10. Priority setting for high cost medications (HCMs) in public hospitals in Australia: a case study.
    Gallego G; Taylor SJ; Brien JA
    Health Policy; 2007 Nov; 84(1):58-66. PubMed ID: 17618009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stratification of drug expenditures incurred by Poles.
    Swistak P; Wikiński M; Swistak J; Błonska-Fajfrowska B
    Wiad Lek; 2007; 60(9-10):429-32. PubMed ID: 18350716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitals' 'hidden' education costs exceed budgeted expenses: study.
    Farmer M
    Hospitals; 1985 Aug; 59(16):116, 118. PubMed ID: 4018763
    [No Abstract]   [Full Text] [Related]  

  • 14. A view from Sofia.
    Jorgova-Makedonska JB
    Circulation; 2006 Mar; 113(12):f45-6. PubMed ID: 16567577
    [No Abstract]   [Full Text] [Related]  

  • 15. $75K can get seven times that in free meds when hospitals know the system.
    Clin Resour Manag; 2000 Mar; 1(3):39-42, 33. PubMed ID: 11183048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the Lublin Regional Health Board contract in 2002 in the selected departments of the state hospital health service of the Lublin region. Part II. Medical staff as a criterion of contract evaluation].
    Grochowski L; Włoch K; Skórzyńska H
    Wiad Lek; 2002; 55 Suppl 1(Pt 2):698-702. PubMed ID: 17474586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription drug spending: contribution to health care spending and cost containment strategies.
    Rivers PA; Hall NG; Frimpong J
    J Health Care Finance; 2006; 32(3):8-19. PubMed ID: 18975728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cost of drugs to guarantee the challenges of the National Health Service].
    Traversa G
    Assist Inferm Ric; 2019; 38(1):36-42. PubMed ID: 30933190
    [No Abstract]   [Full Text] [Related]  

  • 20. Appraising medicines: improving but not perfect.
    Drug Ther Bull; 2013 Dec; 51(12):133. PubMed ID: 24336494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.